Connection
Tarak Srivastava to Receptors, Urokinase Plasminogen Activator
This is a "connection" page, showing publications Tarak Srivastava has written about Receptors, Urokinase Plasminogen Activator.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.033 |
|
|
|
-
Trachtman H, Vento S, Herreshoff E, Radeva M, Gassman J, Stein DT, Savin VJ, Sharma M, Reiser J, Wei C, Somers M, Srivastava T, Gipson DS. Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group. BMC Nephrol. 2015 Jul 22; 16:111.
Score: 0.033